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Abstract 
Purpose: To compare flicker-induced retinal vessel diameter changes in varying age groups 
with low cardiovascular risk. 
Methods: Retinal vascular reactivity to flicker-light was assessed by means of dynamic 
retinal vessel analysis in 57 participants aged 19-30yrs, 75 participants aged 31-50yrs, and 
62 participants aged 51-70yrs participants. Other assessments included carotid intima-media 
thickness (c-IMT), augmentation index (AIx), blood pressure profiles, blood lipid metabolism 
markers, and Framingham risk scores (FRS).  
Results: Retinal arterial dilation amplitude (DA) and post-flicker percent constriction (MC%) 
were significantly decreased in the oldest group compared to the middle-aged (p = 0.028; p 
= 0.021) and youngest group (p = 0.003; p = 0.026). The arterial constriction slope (SlopeAC) 
was also decreased in the oldest group compared to the youngest group (p = 0.027). On the 
venous side, MC% was decreased in the middle-aged and older groups in comparison to the 
youngest group (p = 0.015; p = 0.010, respectively). Additionally, men exhibited increased 
arterial DA (p = 0.007), and percent dilation (MD%, p < 0.001) in comparison to women, but 
only in the youngest age group. Both AIx and c-IMT scores increased with age (both p < 
0.001), however, no correlations were found between the observed differences in the 
measured retinal vascular function and systemic parameters. 
Conclusion: In individuals with low cardiovascular risk, there are age-related differences in 
flicker-induced retinal vessel diameter changes throughout the entire functional response 
curve for arteries and veins. Gender differences mainly affect the arterial dilatory phase and 
are only present in young individuals.  
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Introduction 
It is well known that the incidence and prevalence of cardiovascular disease (CVD) 
increases exponentially with age (McDermott 2007; Rosamond et al. 2008; Nichols et al. 
2013). At present, the current identification of at-risk individuals for primary prevention efforts 
relies on classical risk factors for CVD such as lipid profiles, smoking, and hypertension 
(Grundy et al. 1999; Committee 2012; Goff et al. 2014). Although some of these variables 
increase with age, the predictive accuracy of traditional risk estimates that include the 
aforementioned variables, such as Framingham risk scores (FRS), the Prospective 
Cardiovascular Mὒnster (PROCAM) score, and the European Society of Cardiology 
Systematic Coronary Risk Evaluation (SCORE) either over- or under-estimate actual risk in 
a large number of individuals (Vasan 2006; Koenig 2007; Cohn 2013). Therefore, other 
measures such as genetic, inflammatory, and coagulation markers, as well as, various tests 
for subclinical disease have been sought (Helfand et al. 2009; Wang 2011; Ge &  Wang 
2012). The quantification of vascular and endothelial dysfunction (Deanfield et al. 2007) is a 
recently emerging early marker for CVD and is usually achieved by employing techniques 
such as ultrasound flow mediated dilation (FMD), pulse wave analysis (PWA), 
plethysmography, and iontophoresis (Ray et al. 2014). These tests can, however, be 
complex and time consuming, and are performed only in highly specialized services. Among 
the various methods developed to measure microvascular function, dynamic retinal vessel 
analysis (DVA) features as a non-invasive method that allows for continuous recordings of 
retinal arterial and venous diameter changes in response to flicker-light stimulation. The 
main advantage of the DVA assessment is that it provides integrated and dynamic data 
analysis that is specific to each individual. In addition, its output has proven to be modified 
not only by overt disease but also in the presence of more subtle risk factors for CVD (Pemp 
et al. 2009; Reimann et al. 2009; Kotliar et al. 2011) including ethnicity (Patel et al. 2011) 
and impaired glucose tolerance (Patel et al. 2012). Therefore, it is possible to use the 
assessment of retinal microvascular function as an early marker for vascular and endothelial 
dysfunction.  
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Besides pathologies, however, normal ageing as assessed by DVA can also influence retinal 
microvascular dynamics. Indeed, published data allude to an age-related decrease in retinal 
arterial response profiles (Kotliar et al. 2008), as well as, to a general decline in overall 
vessel dilation amplitudes during flicker-light stimulation (Nagel et al. 2004; Kneser et al. 
2009; Gugleta et al. 2013). Nevertheless, a more complex analysis of the dynamics of both 
vasodilation and vasoconstriction responses, as well as, of the capacity to re-establish a pre-
flicker diameter after the cessation of stress is needed for a better understanding of healthy 
individual vascular dynamics. Therefore, the present study, using a more detailed approach 
for the evaluation of retinal vascular function, seeks to characterize the entire retinal 
microvascular response to flicker provocation in individuals with low cardiovascular risk 
belonging to various age groups.  
Methods 
Study participants 
Community-dwelling volunteers (aged above 18 years) were recruited through local 
advertisements at the Vascular Research Laboratory and Health Clinics at Aston University 
(Birmingham, UK). Ethical approval for the study was received from the relevant local and 
institutional ethics committees. Written informed consent was received from all participants 
prior to study enrolment and all study procedures were designed and conducted in 
accordance with the tenets of the Declaration of Helsinki. 
Study exclusion criteria were defined as a history or current diagnosis of cardiovascular or 
cerebrovascular disease including coronary artery disease, heart failure, arrhythmia, stroke, 
transient ischemic attacks, peripheral vascular disease, as well as, smoking, hypertension, 
diabetes, and or severe dyslipidaemia (defined as plasma triglyceride levels above 6 mmol/L 
or cholesterol levels above 7 mmol/L). The use of vasoactive medications such as dietary 
supplements containing vitamins or antioxidants and bronchodilators also served as 
exclusion criteria. In addition, participants with elevated intraocular pressures (IOP > 21 
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mmHg), retinal disease, intraocular surgery, neuro-ophthalmic disease, cataract or other 
media opacities that may affect the ocular vascular system or prevent retinal vascular 
examination were also excluded from the study. 
General investigations 
All study-related measurements were performed between 8 and 11 AM following a 12-hour 
overnight fast, which included refraining from alcohol or caffeine. 
Standard anthropometric measures of height and weight were recorded to determine body 
mass index (BMI = weight/height2). Systolic blood pressure (SBP), diastolic blood pressure 
(DBP), and heart rate (HR) were measured using an automatic BP monitor (UA-767; A&D 
Instruments Ltd, UK) to determine mean arterial pressure (MAP = 2/3 DBP + 1/3 SBP). IOP 
readings were obtained using non-contact tonometry (Pulsair; Keeler Ltd, UK) to determine 
ocular perfusion pressure (OPP = 2/3 MAP – IOP).  
In addition, blood and plasma samples drawn from the antecubital fossa vein were assessed 
immediately for fasting glucose (GLUC), triglycerides (TG), total cholesterol (CHOL), and 
high-density lipoprotein cholesterol (HDL-c) using the Reflotron Desktop Analyzer (Roche 
Diagnostics, UK). Low-density lipoprotein cholesterol (LDL-c) values were calculated as per 
the Friedewald equation (Friedewald et al. 1972). 
Framingham risk score (FRS) 
The FRS is a widely used gender-specific algorithm originally developed to estimate CVD 
risk (Wilson et al. 1987). In the present study FRS was calculated using the current version 
of the FRS published by an expert panel of the National Heart, Lung and Blood Institute 
(NHLBI) (2002) and is based on risk factors such as age, gender, CHOL, HDL-c, SBP, 
treatment for hypertension, smoking status, and diabetes. Risk factors such as age, 
treatment for hypertension, smoking status and diabetes were identified from self-report 
questionnaires and CHOL, HDL-c, and SBP values were as those determined on the day of 
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study assessment. The scoring algorithm is based on gender-specific points assigned for 
each risk factor variable that can be determined using FRS tables i.e. point scores by age 
group; age group and total CHOL; age group and smoking status; HDL-c level; SBP and 
treatment status. Ten-year risk percentage is then calculated by total points (1 point, 6%; 2 
points, 8%; 3 points, 10%; 4 points, 12%; 5 points, 16%; 6 points, 20%; 7 points, 25%; 10 
points or more, > 30%). Absolute CVD risk percentage over 10 years was classified as low 
risk (< 10%), intermediate risk (10-20%), and high risk (> 20%) (Ford et al. 2004).  
Carotid intima-media thickness (c-IMT) 
Intima-media thickness measurements of the left and right common carotid arteries were 
obtained for all participants as described previously (Seshadri et al. 2015), and in 
accordance with an already published protocol (Salonen et al. 1991).  
Pulse-wave analysis (PWA) 
Arterial stiffness was assessed by PWA using the validated SphygmoCor device according 
to an already published protocol (O'Rourke et al. 2001), and as detailed previously 
(Mroczkowska et al. 2012). The augmentation index (AIx) value calculated by the device 
software was used as a measure of arterial stiffness (Wilkinson et al. 1998). 
Dynamic retinal vessel analysis (DVA) 
Retinal vessel reactivity was measured with the dynamic retinal vessel analyser (IMEDOS 
GmbH, Germany) using a previously published protocol (Nagel et al. 2006). All 
measurements were performed in a quiet, temperature-controlled room (22oC) following full 
pupil dilation with 1% Tropicamide (Chauvin Pharmaceuticals Ltd, UK). For all participants, 
measurements were conducted in one unselected eye. A visual fixation target was used to 
control eye movements and to position the region of interest at the centre of the fundus 
image. Within this region, a segment approximately 0.5 to 1 mm and 1 to 2 disc diameters 
from the optic nerve head was selected for continual diameter recording, for both the inferior 
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temporal retinal artery and retinal vein. The automated 350-second flicker stimulation 
protocol included a 50-second baseline diameter measurement (under still illumination 25 
Hz) followed by three successive cycles of flicker stimulation (opto-electronically generated 
at 12.5 Hz) distinguished as 20 seconds of stimulus interrupted by an 80-second recovery 
period. The dynamic nature of the vessel response profile was further explored by extracting 
the raw response data and applying a statistical polynomial regression algorithm (MATLAB; 
Mathworks, MA) (Mroczkowska et al. 2012). The following vessel reactivity and time course 
parameters, were determined for each flicker cycle and then averaged over the three cycles, 
with the artery and vein regarded separately: the average baseline diameter and range of 
maximum and minimum baseline vessel diameters (baseline diameter fluctuation, BDF); the 
maximum vessel dilation diameter during flicker stimulation expressed as a percentage 
change relative to baseline diameter (MD%) and the time taken in seconds to reach the 
maximum diameter (tMD); the maximum vessel constriction diameter during the post-flicker 
recovery period expressed as a percentage change relative to baseline diameter (MC%) and 
the time taken in seconds to reach the maximum vessel constriction diameter (tMC); the 
overall dilation amplitude (DA) calculated as the difference between MD and MC; and the 
baseline-corrected flicker response (BCFR) used to describe the overall dilation amplitude 
after normalizing for fluctuations in baseline diameters (DA-BDF). In addition, the arterial (A) 
and venous (V) dilation slopes (SlopeAD/VD = (MD-baseline diameter)/tMD) and constriction 
slopes (SlopeAC/VC = (MC-MD)/tMC) were also calculated. 
Statistical Analysis 
All data are reported as mean (SD) unless otherwise indicated. The Shapiro-Wilk test was 
used to determine the distribution of the data. Univariate associations were determined using 
Pearson’s (normally distributed data) or Spearman’s method (non-normally distributed data), 
and forward stepwise regression analyses were performed to test the influences of BMI, BP, 
circulating markers, c-IMT, and AIx on the measured variables. Differences between groups 
were subsequently assessed using one-way analysis of variance (ANOVA) or analysis of 
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covariance (ANCOVA), followed by Tukey’s post-hoc analysis as appropriate. P-values of 
less than 0.05 were considered significant, except in certain cases where a stricter p-value 
of less than 0.01 was adopted in order to correct for multiple comparisons. All analyses were 
performed using the commercially available Statistica® software (StatSoft Inc.; Version 9, 
Tulsa, OK). 
Results  
A total of 236 volunteers were initially screened for study inclusion of which 42 individuals 
were excluded based on having moderate or high FRS (>10%). The remaining 194 
participants with low FRS (<10%) were included in the final analysis and classified into one 
of three age groups (Group 1: 19 to 30yrs; Group 2: 31 to 50yrs; Group 3: 51 to 70yrs). The 
number of participants in each group was similar (Group 1: 57; Group 2; 75; Group 3; 62, 
Chi-square test: p = 0.295), as was the distribution of male (M) and female (F) participants 
within each group (Group 1: M = 27, F = 30; Group 2: M = 42, F = 33; Group 3: M = 33, F = 
29, Chi-square test p = 0.612).  
Clinical characteristics 
Table 1 summarizes the clinical characteristics of the study population. There was a 
significant difference between groups in age (p < 0.001), BMI (p = 0.002), SBP (p = 0.002), 
DBP (p = 0.001), HR (p < 0.001), MAP (p = 0.001), IOP (p < 0.001), CHOL (p = 0.002), HDL-
c (p = 0.007), LDL-c (p < 0.001), FRS (p < 0.001), c-IMT scores (p < 0.001), and AIx (p < 
0.001), but not in OPP (p = 0.089), GLUC (p = 0.102), or TG levels (p = 0.161). Post-hoc 
comparisons revealed that FRS and c-IMT scores significantly increased with age, with each 
group differing significantly from the other (all p < 0.001). In addition, in comparison to the 
youngest group BMI, DBP, IOP, and LDL-c were higher in the middle-aged (p = 0.023, p = 
0.013, p = 0.019, and p = 0.006, respectively) and older (p = 0.002, p = 0.001, p < 0.001, 
and p = 0.001, respectively) groups. SBP and AIx were also higher in the oldest group 
compared to the youngest (p = 0.009; and p < 0.001, respectively) and middle-aged groups 
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(p = 0.003; and p = 0.010, respectively). Finally, with regards to HR, MAP, CHOL and HDL-
c, the middle-aged group did not differ significantly from the youngest or oldest group (all p > 
0.05), however, HR (p < 0.001) and HDL-c (p = 0.009) were lower, and MAP (p < 0.001) and 
CHOL (p = 0.001) were higher in the oldest age group in comparison to the youngest group.  
Retinal vessel diameter  
Group differences in flicker-induced retinal arterial and venous diameter changes (DVA) are 
summarized in Table 2. All reported values are based on data averaged across the three 
flicker cycles, with the artery and vein regarded separately.   
Arterial response 
After controlling for influential covariates identified in multivariate analysis, there were no 
significant group differences in baseline diameter, BDF, BCFR, MD%, tMD, tMC, and 
SlopeAD, (all ANCOVA p > 0.01, Table 2). There were, however, significant group differences 
in arterial DA (p = 0.003), MC% (p < 0.001) and SlopeAC (p < 0.001) (Table 2). Post-hoc 
comparisons showed DA and MC% to be significantly decreased in the oldest age group 
compared to the middle-aged (p = 0.028; p = 0.021, respectively) and youngest groups (p = 
0.003; p = 0.026, respectively). Additionally, SlopeAC was decreased in the oldest age group 
compared to the youngest group (p = 0.027), with the middle-aged group not differing 
significantly from the youngest (p = 0.525) or oldest groups (p = 0.216) (Figure 1A). 
Venous Response 
There was an overall significant difference in venous MC% across groups (ANOVA p = 
0.002) with post-hoc comparisons showing MC% to be similarly decreased in the middle-
aged (p = 0.015) and older (p = 0.010) groups in comparison to the youngest group (Figure 
1B). After controlling for influential covariates no significant group differences in any of the 
other measured venous DVA parameters were identified (ANCOVA, all p > 0.05, Table 2).  
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Gender comparisons 
Arterial MD% was significantly higher in men compared to women with regards to the study 
population as a whole (M: 4.42 ± 2.51 vs. F: 3.84 ± 2.27, p = 0.011, Figure 2). Within-group 
gender comparisons in the measured retinal arterial DVA parameters are displayed in Table 
3. Arterial DA (p = 0.007) and MD% (p < 0.001) were significantly higher in men compared to 
women belonging to the youngest age group (Figure 3, Table 3) but not between men and 
women in the middle-aged and oldest groups (all p > 0.01). There were, no significant 
differences between men and women in any of the other measured arterial DVA parameters 
for the study population or within groups (all p > 0.01, Table 3). There were also no 
significant gender differences in any of the measured venous DVA parameters (all p > 0.01, 
data not shown). 
Discussion 
In the present study we used a specific computational model to evaluate the entire dynamic 
response of retinal microvessels after flicker stimulation in a sample of individuals with low 
CVD risk belonging to various age groups. Our results show that independent of systemic 
influences, older healthy individuals displayed abnormal dilatory and constrictory responses 
to flicker-light stimulation in retinal arteries and veins. Additionally, in younger individuals, 
gender had an influence on retinal arterial dilation. This effect was, however, lost in the 
middle-aged and oldest groups.  
It is known that decreased vessel distensibility and focal narrowing occur in ageing vessels 
independently of other arteriosclerotic risk factors such as hypertension (Van Bortel &  Spek 
1998; Hubbard et al. 1999; Wong et al. 2003). Despite various adaptations to vascular 
structural remodelling and changes in viscoelastic properties that occur with ageing, there 
could still be individual limitations in functional vascular reserves that may only be evident as 
responses to provocative stressors. In line with previous research (Nagel et al. 2004; Kneser 
et al. 2009), this study shows an age-related decline in retinal vasoregulative capacity in 
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both dilatory and constrictory phases that was independent of any systemic influences. It 
was previously hypothesized that in ageing vessels this vascular adaptive response may be 
attributed to a re-setting of vessels’ average working points within which the points of 
maximum dilation and constriction tend to occur (Kneser et al. 2009). The cause of this shift 
in vessel behaviour remains unclear; however, a possible contender is a high level of 
oxidative stress that occurs with ageing and is a known cause of senescent endothelial 
dysfunction (Heo et al. 2011). Indeed, we have already demonstrated that in otherwise 
healthy individuals with low to moderate cardiovascular risk, retinal microvascular dilation 
and constriction responses to stress levels are influenced by systemic antioxidant capacity 
(Seshadri et al. 2015). Although the levels of antioxidant molecules were not determined in 
this study, it can be hypothesized that similar interactions take place in individuals with 
similar CVD risk.  
Other factors such as age-related vascular stiffness can also be involved. An understanding 
of microcirculatory responses with regards to systemic haemodynamic parameters is 
important as the combination of age-related arterial stiffening and ensuing hypertension 
(O'Rourke 2007) can offset the stiffness gradient between the heart and periphery and 
augment pressure pulsatility penetrating into the microvasculature. Indeed, in our study 
groups the AIx, a measure of peripheral arterial stiffness, was higher in the older group than 
in middle-aged or younger individuals. In normal microvessels, low resistance protects them 
from intense pulsations and flow fluctuations, nevertheless, it is well known that this balance 
can be modified by age-related stiffening of the vascular wall, resulting in microcirculatory 
damage (Barodka et al. 2011). Although the age-related decline in the retinal vessels’ 
dilation and constriction phases demonstrated in our study occurred independently of 
systemic factors, it cannot, however, be excluded that local microvascular stiffness played 
some role in our findings.  
In previous studies we have already documented increases in pre-flicker baseline diameter 
fluctuations (Mroczkowska et al. 2013), decreases in the arterial corrected flicker response 
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(Patel et al. 2012) and dilation capacity (Qin et al. 2013), as well as, venous dilation capacity 
(Mroczkowska et al. 2012) and enhanced post-flicker vasoconstrictions (Mroczkowska et al. 
2012; Mroczkowska et al. 2013) in individuals with various levels of cardiovascular risk. In 
the present study, in a sample with low risk, decreases in the post-flicker constrictory phase 
of retinal veins were apparent in the middle-aged and older individuals. The role of the 
venular circulation in CVD has previously received limited attention until unexpected 
associations implicated retinal venular dilation, rather than arteriolar narrowing, as a stronger 
predictor of adverse vascular phenomena (Wong et al. 2006; Wang et al. 2007; Wong &  
Mitchell 2007). These studies have since stimulated an increased interest in retinal venular 
physiology although it remains unclear whether venous changes detected by the DVA 
represent separate causal pathways of endothelial dysfunction, or are epiphenomena of the 
arterial response. In such a context, it could be possible that the observed decrease in post-
flicker venous diameters returns reflects a compensatory adaptation following sustained 
arterial dilation during flicker. Further investigation is required to understand the relevance of 
an impaired venous constriction post-flicker, however, it could be hypothesized that a 
change in venous caliber associated with either structural or endothelial irregularities could 
also be used as a marker for ageing and associative cardiovascular risk.  
The dynamic behaviour of retinal microvessels also appears to be affected by more than just 
the ageing functional state of the endothelium. In the present study, gender differences in 
the retinal vasoregulative response were lost with ageing. Sex hormones influence both 
vascular tone and blood flow in various organs and tissues, including retinal vessels (Ogueta 
et al. 1999). Taking into consideration the above, gender differences in vascular tonus and 
blood flow are to be expected due to changes in hormonal status across the life span of 
individuals.  Indeed, in the present study we have observed an overall gender difference in 
arterial MD%; however with younger men exhibiting higher MD% values than age-matched 
women. To our knowledge, this is the first study to observe gender differences in DVA 
measurements in healthy individuals and as oestrogens upregulate NO production and 
suppress the effect of vasoconstrictors such as endothelin-1 (Kauser &  Rubanyi 1997), our 
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results are somewhat unexpected. As the retinal vascular response to flickering light is also 
a neurovascular coupling driven response (Riva et al. 2005) and sex hormones can exert 
effects on other cells in the neurovascular unit such as neurons and astrocytes (Yang et al. 
2005), it is possible that the gender differences in flicker-induced retinal diameter changes 
do not truly match those assessed by other methods that measure resting blood flow and 
vascular tone. Nevertheless, the expected ageing-related blunt with regards to gender 
differences in vascular reactivity was still apparent in our results. More work is, however, 
necessary in order to clarify the mechanism of gender differences in flicker-induced retinal 
diameter changes as measured by DVA. 
Conclusion 
In conclusion this study demonstrates that age and gender are variables to be considered 
when assessing the retinal vascular response to flicker stimulation. In addition, the entire 
retinal microvascular response to flicker provocation, as well as, the age and gender of each 
individual should be considered when assessing possible pathological changes associated 
with vascular disease by means of the DVA. 
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Figure Legends 
Figure 1. Comparison of retinal (A) arterial and (B) venous response profiles across age 
groups. AU, arbitrary units; MD, maximum dilation diameter during flicker; DA, dilation 
amplitude (MD-MC), MC, maximum constriction diameter post-flicker; MC%, percentage 
constriction below baseline; SlopeAC, arterial constriction slope (MC-MD/time taken to reach 
MC).  
Figure 2. Comparison of the retinal arterial response profile between men and women in the 
study population. AU, arbitrary units; MD, maximum dilation diameter; MD%, percentage 
change in diameter from baseline to maximum during flicker; MC, maximum constriction 
diameter post-flicker.  
Figure 3. Comparison of the retinal arterial response profile between men and women in the 
youngest age group (19-30yrs). AU, arbitrary units; MD%, percentage change in diameter 
from baseline to maximum during flicker; DA, dilation amplitude; MD, maximum dilation 
diameter during flicker; MC, maximum constriction diameter post-flicker. 
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Table 1. Summary of systemic characteristics a. 
 
 
Characteristic 
Group (1) 
(19-30yrs) 
Group (2) 
(31-50yrs) 
Group (3) 
(51-70yrs) 
p-value 
Significant 
difference by 
group 
 
No. of participants 
 
57 
 
75 
 
62 
 
0.295 
 
- 
Gender distribution 27M : 30F 42M : 33F 33M : 29F 0.612 - 
Age (years) 26 (3) 40 (6) 56 (5) <0.001c 1 < 2 < 3 
BMIb 24.11 (3.84) 26.00 (3.74) 26.69 (4.69) 0.002c 1 < 2, 3; 2 = 3 
SBP (mmHg) 116 (13) 117 (12) 123 (13) 0.002c 1, 2 < 3; 1 = 2 
DBP (mmHg) 71 (9) 76 (11) 77 (10) 0.001c 1 < 2, 3; 2 = 3 
HR (bpm) 71 (11) 67 (8) 64 (8) <0.001c 1 > 3; 2 = 1, 3 
MAP 85.94 (9.33) 89.63 (10.67) 92.92 (10.26) 0.001c 1 < 3; 2 = 1, 3 
IOP (mmHg) 13 (2) 14 (3) 15 (2) <0.001c 1 < 2, 3; 2 = 3 
OPPd 44.69 (6.06) 45.97 (7.08) 47.44 (7.09) 0.089 - 
GLUC (mmol/L) 4.80 (0.74) 4.92 (0.68) 5.09 (0.78) 0.102 - 
TG (mmol/L) 1.04 (0.47) 1.22 (0.65) 1.18 (0.50) 0.161 - 
CHOL (mmol/L) 4.18 (0.77) 4.49 (0.89) 4.75 (0.97) 0.002c 1 < 3; 2 = 1, 3 
HDL-c (mmol/L) 1.44 (0.50) 1.38 (0.41) 1.22 (0.38) 0.007c 1 > 3; 2 = 1, 3 
LDL-c (mmol/L) 2.25 (0.75) 2.71 (0.86) 2.82 (0.91) <0.001c 1 < 2, 3; 2 = 3 
FRS % 0.74 (0.48) 3.41 (2.41) 8.25 (2.71) <0.001c 1 < 2 < 3 
c-IMT (mm) 0.46 (0.01) 0.56 (0.01) 0.63 (0.02) <0.001c 1 < 2 < 3 
AIx 10 (9) 15 (12) 22 (12) <0.001c 1, 2 < 3; 1 = 2 
 
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; MAP, mean arterial pressure; IOP, intraocular pressure; OPP, ocular perfusion 
pressure; GLUC, glucose; TG, triglycerides; CHOL, total cholesterol; HDL-c, high-density lipoprotein 
cholesterol; LDL-c, low-density lipoprotein cholesterol; FRS, Framingham risk score; c-IMT, carotid 
intima-media thickness; AIx, augmentation index. 
a Data are presented as mean (SD) unless otherwise indicated. 
b Calculated as weight in kilograms divided by height in metres squared. 
c p < 0.05 was considered a significant difference. 
d Calculated as MAP = 2/3 DBP + 1/3 SBP. 
e Calculated as OPP = 2/3 MAP – IOP.  
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Table 2. Retinal arterial and venous vascular function parameters (DVA). 
 
Parameter 
Mean (SD) 
p-value 
Significant 
difference by 
group 
Group (1) 
(19-30yrs) 
Group (2) 
(31-50yrs) 
Group (3) 
(51-70yrs) 
Arteries:      
Baseline 99.89 (0.76) 99.97 (0.20) 99.98 (0.14) 0.488 - 
BDF 6.06 (3.29) 5.93 (2.59) 5.54 (2.78) 0.093 - 
DAb 7.04 (3.61) 6.59 (2.72) 5.36 (2.36) 0.003a 1, 2 > 3; 1 = 2 
BCFRc 1.05 (3.03) 0.90 (2.65) 0.03 (2.36) 0.083 - 
MD% 4.38 (3.00) 4.09 (2.22) 3.82 (2.04) 0.036 - 
MC% -2.67 (2.32) -2.41 (1.67) -1.37 (1.77) <0.001a 1, 2 > 3; 1 = 2 
tMD (sec) 22 (9) 20 (8) 21 (7) 0.105 - 
tMC (sec) 24 (9) 28 (9) 29 (8) 0.041 - 
SlopeADd 0.23 (0.15) 0.27 (0.16) 0.28 (0.41) 0.063 - 
SlopeACe -0.42 (0.35) -0.27 (0.57) -0.23 (0.20) <0.001a 1 > 3; 2 = 1, 3 
Veins:      
Baseline 99.89 (0.76) 99.98 (0.13) 99.96 (0.20) 0.490 - 
BDF 4.83 (2.78) 3.99 (1.63) 4.64 (2.82) 0.114 - 
DAb 5.80 (3.33) 5.25 (2.53) 5.51 (2.78) 0.557 - 
BCFRc 1.05 (2.67) 1.30 (2.29) 0.92 (2.55) 0.097 - 
MD% 4.31 (2.19) 4.59 (2.43) 4.46 (2.74) 0.794 - 
MC% -1.61 (1.70) -0.81 (1.10) -0.75 (1.16) 0.002a 1 > 2, 3; 2 = 3 
tMD (sec) 23 (8) 21 (6) 22 (7) 0.129 - 
tMC (sec) 28 (9) 30 (7) 29 (7) 0.390 - 
SlopeVDd 0.23 (0.15) 0.25 (0.14) 0.26 (0.17) 0.391 - 
SlopeVCe -0.25 (0.17) -0.19 (0.15) -0.22 (0.16) 0.087 - 
Abbreviations: DVA, dynamic retinal vessel analysis; baseline, baseline diameter; BDF, baseline 
diameter fluctuation; DA, dilation amplitude; BCFR, baseline corrected flicker response; MD%, 
percentage change in diameter from baseline to maximum; MC%, percentage constriction below 
baseline; tMD, reaction time to maximum dilation diameter; tMC, reaction time to maximum 
constriction diameter from maximum dilation diameter; SlopeAD/VD, slope of arterial/venous dilation; 
SlopeAC/VC, slope of arterial/venous constriction. Unless otherwise indicated, all values are expressed 
in arbitrary units, which approximately correspond to micrometres (μM) in a normal Gullstrand eye.  
a p < 0.01 was considered a significant difference. 
b Calculated as MD – MC. 
c Calculated as DA – BDF (Nagel et al. 2004). 
d
 Calculated as (MD – baseline)/tMD (Mroczkowska et al. 2012). 
e Calculated as (MC – MD) / tMC (Mroczkowska et al. 2012).  
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Table 3. Group comparisons of retinal arterial vascular function parameters (DVA). 
Parametera 
Mean (SD) 
Group 1 (19-30yrs) Group 2 (31-50yrs) Group 3 (51-70yrs) 
M F p M F p M F p 
Baseline 99.79 (1.07) 100.00 (0.01) 0.288 99.99 (0.07) 99.95 (0.27) 0.414 99.97 (0.19) 100.00 (0.01) 0.306 
BDF 6.95 (3.50) 5.36 (2.77) 0.059 5.99 (2.40) 5.92 (2.48) 0.895 5.05 (1.57) 6.02 (3.09) 0.137 
DA 8.21 (4.01) 5.72 (2.75) 0.007b 6.38 (2.69) 7.01 (2.82) 0.298 5.53 (2.27) 5.43 (2.64) 0.872 
BCFR 1.26 (3.44) 0.48 (2.64) 0.336 0.46 (2.94) 1.09 (2.16) 0.277 0.50 (2.15) -0.37 (2.55) 0.120 
MD% 5.85 (3.29) 3.06 (1.80) <0.001b 3.93 (2.08) 4.61 (2.53) 0.175 3.97 (1.96) 3.71 (2.14) 0.592 
MC% -2.37 (2.82) -2.66 (1.88) 0.654 -2.45 (1.55) -2.41 (1.68) 0.895 -1.56 (1.72) -1.72 (1.73) 0.687 
tMD (sec) 23 (10) 21 (7) 0.222 19 (7) 22 (8) 0.080 20 (7) 21 (8) 0.316 
tMC (sec) 23 (10) 26 (8) 0.148 29 (7) 25 (9) 0.027 29 (8) 27 (8) 0.232 
SlopeAD 0.29 (0.18) 0.20 (0.17) 0.071 0.27 (0.16) 0.27 (0.17) 0.991 0.28 (0.31) 0.31 (0.49) 0.757 
SlopeAC -0.50 (0.28) -0.35 (0.37) 0.081 -0.26 (0.13) -0.50 (0.72) 0.022 -0.24 (0.14) -0.29 (0.19) 0.289 
Abbreviations; DVA, dynamic retinal vessel analysis; M, men; F, women; Baseline, baseline diameter; BDF, baseline diameter fluctuation; DA, dilation 
amplitude; BCFR, baseline corrected flicker response; MD%, percentage change in diameter from baseline to maximum; MC%, percentage constriction below 
baseline; tMD, reaction time to maximum dilation diameter; tMC, reaction time to maximum constriction diameter from maximum dilation diameter; SlopeAD/VD, 
slope of arterial/venous dilation; SlopeAC/VC, slope of arterial/venous constriction. Unless otherwise indicated, all values are expressed in arbitrary units, which 
approximately correspond to micrometres (μM) in a normal Gullstrand eye.  
a See Table 2 footnotes b through e for calculations of DA, BCFR, SlopeAD and SlopeAC. 
b p < 0.01 was considered a significant difference.  
 
